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1. Introduction 
Sensations from various parts of the body are taken by the peripheral sensory nerves to the 
spinal cord. From spinal cord, the signals reach the brain with the help of the trigeminal 
nerve and brain stem. Hence, any problem in this pathway may result in paresthesia. 
Paresthesia is an abnormal condition which causes an individual to feel a sensation of 
burning, numbness, tingling, itching or prickling. It frequently happens in the extremities, 
but it can occur in other parts of the body as well. 
The purpose of this chapter is to review the causes of paresthesia from studies indexed in 
PubMed. We describe the underlying conditions that may cause paresthesia based on two 
subdivisions: Transient and Chronic Paresthesias. 
2. Causes of transient paresthesia 
This paresthesia subtype involves temporary numbness or tingling that disappears quickly 
as can occur from sitting with your legs crossed for a long time or sleeping on your arm in a 
bent position. This is a very common type of paresthesia. 
• Obdormition: Obdormition is a numbness caused by prolonged pressure on a nerve, 
such as when a leg falls asleep if the legs are crossed for a prolonged period. It 
disappears gradually as the pressure is relieved (1). 
• Whiplash: Paresthesias in the upper extremity may occur after whiplash injury (2), a 
type of cervical soft tissue injury (3). Pujol et al showed that 13% of patients with 
whiplash had associated paresthesias (4). Recovery usually arises within 6 months after 
injury (5). 
• Hyperventilation syndrome: Paresthesia constitutes 35% of presenting complaints in 
patients with hyperventilation syndrome (6) and may begin after as little as three-
minute of hyperventilation (7). After increasing the depth or frequency of respiration, 
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the alkaline shift produced selectively increases Na+ conductance and ectopic 
discharges in normal cutaneous afferent nerves can be induced (8). Other electrolytes, 
i.e. magnesium, potassium, chloride, phosphate and bicarbonate, also demonstrated 
significant changes in concentration (7).  
• Panic attack: Paresthesiae of the mouth, hands and feet are common, transient 
symptoms of the related conditions of hyperventilation syndrome and panic attacks. 
Ietsugu et al demonstrated that paresthesia can be used as a reliable indicator of severe 
panic attacks (9).  
• Transient ischemic attack (TIA): TIA may be manifested by paresthesias. Several 
reasons may cause TIA such as thrombosis, embolus, intravascular debris and blood 
vessels disruption. Perez et al. reported the initial manifestation of cardiac myxoma 
can be paresthesias caused by TIA (10). Post-ischemic paresthesia occurs when hyper 
polarization by the Na+/K+ pump is transiently halted by elevated extracellular K+. 
The electrochemical gradient for K+ is reversed and inward transport of K+ triggers 
regenerative depolarization (8). 
• Seizures: Paresthesia may happen during and after a partial seizure (11). Treatment of 
seizures with vagus nerve stimulation can also trigger paresthesias and is considered an 
adverse event associated with this treatment modality (12). 
• Dehydration: At around 5% to 6% cumulative water loss, paresthesia may occur. 
• Insufficient blood supply: Circulatory disorders could lead to transient or chronic 
paresthesia.  
Acute arterial occlusion by an embolism or in situ thrombosis is a dramatic event which 
produces severe ischemia of distal tissue. The warning signs are the 5 Ps: pallor, pain, 
pulselessness, paralysis and paresthesia. In such cases, emergent restoration of blood flow 
by surgery may be vital to prevent limb loss (13). Aneurysms and dilated forms of 
atherosclerosis can be both the cause of in situ thrombosis as well as the source of an 
embolism (14).  
In Buerger's disease (thromboangiitis obliterans), an occlusive intraluminal thrombus with a 
predominantly acute inflammatory infiltrate causes ischemic ulcers, claudication, 
paresthesia and pain at rest (15, 16). 
Raynaud's syndrome describes a condition characterized by the sensation of coldness, 
burning pain or numbness in the fingers or toes. This syndrome occurs when the blood 
vessels in the fingers or toes spasm, restricting the flow of blood. Some causative factors can 
activate Raynaud's syndrome including contact to cold and emotional stress (17, 18). 
• Apheresis: Because of improvements in technique and instrumentation used for 
apheresis, symptoms of mild ionized hypocalcemia, such as paresthesias or 
lightheadedness, are increasingly easily manageable and quickly reversible with flow-
rate adjustments. Puig et al. reported a 2.27 percent incidence of paresthesia in 
therapeutic apheresis (19). 
• Beta-alanine ingestion: Beta-alanine supplementation is used as a nutritional strategy to 
improve high-intensity anaerobic performance (20). Paresthesia may be observed if a 
single dose higher than 800 mg is ingested but is transient and abates as plasma 
concentration declines. This side effect can be prevented by using controlled release 
capsules and smaller dosing strategies (21).  
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3. Causes of chronic paresthesia 
Chronic paresthesia or intermittent paresthesia over a long period of time is generally a sign 
of neurological disease or traumatic nerve damage. Paresthesia usually arises from nerve 
damage due to infection, inflammation, trauma, or other abnormal process. Paresthesia is 
rarely due to life-threatening disorders, but it can occur as a result of stroke and tumors. 
Whereas paresthesia is a loss of sensation, paralysis usually involves both a loss of 
movement and sensation. 
• Nervous System Disorders 
Paresthesias are common manifestations of central and peripheral pathological processes 
and are due to ectopic impulse activity in cutaneous afferents or their central projections (8).  
• Central nervous system etiologies 
In the central nervous system, the most common etiologies of paresthesia include 
ischemia, compressive phenomena, infection, inflammation, and degenerative 
conditions (22). 
• Stroke: Paresthesia and sensory deficits are considered as signs of stroke (23). In 
unusual cases, mandibular or ear paresthesia may be the only presenting 
symptom of a cerebrovascular accident (24). A persistent unpleasant numbness 
after a cerebrovascular accident can result from central poststroke paresthesia (25).  
• Paresthesia may be caused by selective lacunar infarcts in the diencephalic and 
mesencephalic regions or in the diaschisis in the parietal cortex. Chang and 
Huang reported a patient who presented with unilateral paresthesia after acute 
isolated infarct of the splenium (26). Kim reported that paresthesia or pain 
occurred between 0 to 24 months after lenticulocapsular hemorrhage, more 
prominently in the leg than other body parts (27). In another case report, a 
thalamic lacunar infarct led to sudden isolated left-sided paresthesia involving 
the face, upper and lower limbs (28). Cheiro-oral syndrome is characterized by 
paresthesia and sensory impairment confined to the perioral region and 
ipsilateral fingers or hand, and arises from small stroke-related lesions to 
various sites between the medulla and cortex (29). 
• Intra-cerebral hemorrhage: Paresthesia is a symptom of acute intra-cerebral 
hematoma (30). Epidural or subdural hematoma or subarachnoid hemorrhage 
should be considered as part of the differential diagnosis for acute paresthesia 
and extremity weakness (31-33). Kishida et al. reported that a small hematoma 
localized in the ventroposterior lateral nucleus caused paresthesia limited to 
the forearm and the palm (34).  
• Brain tumor: A sudden numbness especially when accompanied by headache, 
nausea or vomiting, double vision, or weakness could suggest a possible brain 
tumor or metastasis (35). Cavernous angioma which typically presents with 
neurological deficits, low back pain and sciatica or as a subarachnoid 
hemorrhage could be a cause of paresthesia (36). A small round tumor of the 
somatosensory cortex may present with radicular hand pain and paresthesia 
(37). Trigeminal sensory neuropathy presents with anesthesia and paresthesia 
of the orofacial region may herald underlying malignancy (38). Syringomyelia, 
which is generally related to congenital malformations and tumors, may lead 
to paresthesia (39).  
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• Head trauma: Brain injury patients report high rates of complaints generally 
recognized as being associated with neuropsychological impairment such as 
paresthesia (40). Trigeminal trophic syndrome is an unusual complication after 
peripheral or central damage to the trigeminal nerve, characterized by 
anesthesia, paresthesias, and ala nasi ulceration. It can be preceded by head 
trauma, iatrogenic injury or other causes (41, 42). 
• Encephalitis and meningitis: Brain inflammations may lead to paresthesia (43). 
Eosinophilic meningitis is typically induced by the nematode Angiostrongylus 
cantonensis and presents with headache, vomiting and fever, and may also 
induce paresthesia and neck stiffness (44). 
• Abscess: A primary brain abscess may begin with neurologic deficit such as 
paresthesia (45, 46).  
• Lumbar spinal stenosis: 70% of patients experience paresthesia which is 
exacerbated by extension, and improves with spinal flexion (47, 48). 
• Systemic lupus erythematosus: Systemic vasculitis may present with multiple 
neurologic and psychiatric symptoms due to involvement of the central and 
peripheral nervous systems. Painful paresthesias and weakness of the limbs 
have been reported in cases of systemic lupus erythematosus (49, 50).  
• Multiple sclerosis: One of the most common presenting symptoms in Multiple 
Sclerosis is paresthesia (51, 52). About 40% of the patients reported that such 
symptoms had an important adverse influence on daily activities. Painful 
paresthesia leads to avoidance of any triggering activities (53). 
• Transverse myelitis: Sensory impairment and paresthesia in the extremities are 
two common presentations of acute transverse myelitis (54-57). That is a 
relatively uncommon neurological disease in which affected patients exhibit 
acute dehabilitating symptoms associated with the loss of spinal cord segment 
function. 
• Spinal puncture: Paresthesia rarely occurs during spinal puncture or injection 
of local anesthetic for spinal anesthesia (58). A paresthesia may result from 
needle-to-nerve contact with a spinal nerve in the epidural space, or, with far 
lateral needle placement, such as during placement of a spinal needle into the 
intervertebral foramen (59). It seems that lateral decubitus position results in a 
higher incidence of paresthesiae than the sitting position (60). 
• Vitamin B12 deficiency: Neurological symptoms such as paresthesia are 
frequent in vitamin B12 deficiency (61, 62). However therapeutic response to 
vitamin B12 with resolution of associated symptoms is dramatic (63).  
• Peripheral nervous system etiologies (with or without pain) 
The most common source of paresthesia is peripheral neuropathy.  
Cutaneous afferents nerves are more volatile than motor axons, due to differences 
in their biophysical properties. These differences maybe include more persistent 
Na+ conductance and inward rectification on cutaneous afferents, properties which 
probably give greater protection from impulse-dependent conduction failure but 
produce a greater tendency for ectopic activity (8). 
• Entrapment neuropathies 
Numbness and paresthesia are two more common complaints in patients with 
peripheral neuropathies (64). 
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• Carpal tunnel syndrome: Carpal tunnel syndrome is the most common 
entrapment neuropathy caused by compression of the median nerve 
within the carpal tunnel. It is characterized by pain and paresthesia, with a 
usual night exacerbation and aggravation by activity along the distribution 
of the median nerve (65-67).  
• Lateral femoral cutaneous syndrome: Meralgia paresthetica is a rarely 
encountered sensory mononeuropathy characterized by paresthesia, pain 
or sensory impairment along the distribution of the lateral femoral 
cutaneous nerve (LFCN) caused by entrapment or compression of the 
nerve as it crosses the anterior superior iliac spine and runs beneath the 
inguinal ligament. Ultrasound-guided blockade of the LFCN is a safe and 
success technique to treat this condition (68, 69). 
• Isolated femoral neuropathy: This neuropathy occurs due to direct 
compression of the femoral nerve, indirect compression by the psoas 
muscle during pelvic surgery, direct ischemia of the nerve by clamping of 
the iliac artery during the vascular anastomosis or vessel dissection, or by 
postoperative hematoma in the retroperitoneum or psoas muscle. Isolated 
femoral neuropathy causes numbness and paresthesia located in the 
anteromedial part of the thigh (70).  
• Tarsal tunnel syndrome: Paresthesia in the foot is the most frequent 
symptom of tarsal tunnel syndrome and may have an arterial etiology (71). 
Kim and Childers suggested ultrasound-guided injection of 0.5% lidocaine 
to temporarily resolve the paresthesia as a diagnostic modality (72). 
• Sciatica: Sciatica is commonly due to a prolapsed intervertebral disc, although 
spinal canal stenosis, spondylolisthesis, piriformis syndrome, spinal tumours 
and other causes must be considered. Leg pain, paresthesia and weakness are 
the most bothersome symptoms in sciatica (73-75).  
• Disc herniation: Radicular compression by a disc herniation may lead to the 
radiating paresthesia into the extremities (76, 77) 
• Cervical spondylosis: Hand paresthesia is a frequent and early symptom found 
in patients either with cervical spondylosis or carpal tunnel syndrome (78). In 
cervical spondylosis, paresthesia is not commonly nocturnal, aggravated by 
hand activity, or associated with hand pain, in contrast to carpal tunnel 
syndrome (67). 
• Pressure palsy: Paresthesia may be a presenting complaint in pressure palsy 
(79). Hereditary neuropathy with liability to pressure palsies (HNPP) is an 
autosomal-dominant inherited disease clinically characterized by painless and 
episodic or recurrent neurological symptoms such as peripheral palsy or 
paresthesia, often preceded by minor trauma or toxic damage (80, 81). 
However, the presence of mild symptoms and the marked phenotypic 
variability of the disease result in underdiagnosis of HNPP (82). 
• Charcot-Marie-Tooth disease: Charcot-Marie-Tooth hereditary neuropathy 
refers to a group of disorders characterized by a chronic motor and sensory 
polyneuropathy (83). The affected individual typically has distal muscle 
weakness and atrophy often associated with mild to moderate sensory loss, 
depressed tendon reflexes, high-arched feet, severe cramps and painful 
paresthesia (83, 84)  
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• Amyloid neuropathy: In 1975, Kyle and Bayrd investigated 236 cases of 
amyloidosis and reported that paresthesia was one of the most common 
presenting symptoms besides fatigue, light-headedness and weight loss (85). 
Paresthesia may have a glove and stocking or even thoraco-abdominal 
distribtuion (86).  
• Repetitive motion or prolonged vibration: Nerve compression in repetitive 
motion disorders is being recognized with increasing frequency. The 
pathophysiology of chronic nerve compression spans a broad spectrum 
beginning with subperineurial edema and progressing to axonal degeneration. 
The changes seen depend on the amount and duration of the compressive 
forces and lead to pain, tingling, numbness and paresthesia (87). 
• Neuralgia: Neuralgia is a painful sensation in one or multiple nerve 
distribution which can be mild or severe, and acute or chronic. Many patients 
with neuropathic pain exhibit persistent or paroxysmal pain and paresthesias 
that are independent of any stimulus (88).  
• Removal of impacted mandibular third molars (M3s): Extraction of impacted 
M3s may cause temporary or permanent neurosensorial disturbances of the 
inferior alveolar and lingual nerves (89, 90). 
• Circulatory disorders (As mentioned before, insufficient blood supply could lead to 
transient or chronic paresthesia). 
• Thoracic outlet syndrome (TOS) 
• Arterial TOS. The symptoms of Arterial TOS include digital ischemia, claudication, 
pallor, coldness, paresthesia and pain in the hand but seldom in the shoulder or 
neck. These symptoms are the result of arterial emboli arising either from mural 
thrombus in a subclavian artery aneurysm or from a thrombus forming just distal 
to a focus of subclavian artery stenosis. 
• Venous TOS. Paresthesia in the fingers and hands is common in venous TOS and 
may be secondary to swelling in the hand rather than to nerve compression in the 
thoracic outlet area. 
• Neurogenic TOS. Pain, paresthesia, and weakness in the hand, arm, and shoulder, 
plus neck pain and occipital headaches are the classical symptoms of Neurogenic 
TOS. Raynaud’s phenomenon, hand coldness and color changes is also frequently 
seen in NTOS. It is the latter symptoms that can lead to an erroneous diagnosis of 
Arterial TOS (91).  
• Metabolic disorders  
• Diabetes: The most common causes of paresthesia in the United States are diabetes 
and alcoholism (22). Sensory nerve dysfunction is a progressive form of diabetic 
neuropathy, and is often accompanied by other microvascular complications. This 
complication is more common in middle aged and elderly men with type 2 diabetes 
mellitus (92).  
• Alcoholism: The most common complication of chronic alcohol intake is a toxic 
polyneuropathy. Nutritional deficiency as well as the direct neurotoxic effects of 
ethanol or its metabolites can cause alcoholic neuropathy (93). This neuropathy is 
manifested by distal sensory disturbances with pain and paresthesia in a glove and 
stocking pattern (94).  
• Hypoglycemia: Specific symptoms and signs may vary by age, the severity of the 
hypoglycemia and the speed of the decline in blood sugar. Paresthesia may be a 
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neuroglycopenic or adrenergic manifestations of hypoglycemia. Recurrent 
hypoglycemia which is commonly seen in patients with an insulinoma causes 
periodic weakness, vertigo and perioral paresthesia (95). 
• Hypothyroidism: Paresthesia is a more frequent clinical manifestation observed in 
hypothyroidism (96, 97). About 40% of hypothyroid patients have predominantly 
sensory signs of a sensorimotor axonal neuropathy early in the course of thyroid 
disease. It appears that the axonal myelin sheath begins to degenerate without 
sufficient thyroid hormone, and regeneration of damaged nerves also slows (98).  
• Hypoparathyroidism: Hypoparathyroidism is the most common cause of 
hypocalcemia. Acute hypocalcemia causes increased neuromuscular irritability 
which in milder forms lead to paresthesia and numbness of acral and perioral areas 
(99, 100). 
• Hyperaldosteronism: Most clinical effects of hyperaldoste-ronism result from 
hypokalemia, which increases neuromuscular irritability and produces weakness, 
paralysis, and paresthesia (101).  
• Menopause: One of the most common reported somatic symptoms is paresthesia in 
the extremities (102). Decreasing estrogen production causes decreased structural 
effectiveness of collagen and thinning of the skin. This leads to reduced blow flow 
to the superficial nerves and symptoms of numbness and tingling (103). 
• Abnormal blood levels of calcium, potassium or sodium (See Hyperventilation 
syndrome in Causes of transient paresthesia)  
• Uremia: Polyneuropathy is one of the most frequent manifestations in chronic 
uremia. Hemodialyzed uremic patients have been found to have vitamin B6 
deficiency which may lead to paresthesia (104). Uremia can also cause restless legs 
syndrome which is clinically defined as an urge to move the legs with or without 
associated paresthesia (105).  
• Porphyria: The most common symptoms of porphyria are abdominal pain, 
peripheral polyneuropathy, flaccid paresis, with or without autonomic 
involvement (106). Nerve biopsy shows segmental demyelination and axonal 
degeneration and also many small vacuolations are seen in the cell body of affected 
nerves (107). 
• Amyloidosis (See Amyloid neuropathy in Peripheral nervous system etiologies) 
• Infections and post-infection syndromes  
• Herpes simplex virus: Herpetic infection causes paresthesia. Immunohistochemical 
studies suggest that sensory ganglion infection occurs via centripetal axonal 
migration of the virus (108). Topical caffeine can inhibit this paresthesia through 
direct action on sensory neurons (109). 
• Herpes zoster virus: Primary infection by varicella-zoster virus (VZV) may be 
associated with several neurologic complications such as paresthesia (110, 111). 
VZV remains dormant in dorsal root and cranial nerve ganglia and can be 
reactivated as a consequence of declining VZV-specific cellular immunity leading 
to herpes zoster (shingles) (112). Following reactivation, centrifugal migration of 
herpes zoster virus occurs along sensory nerves to produce a characteristic painful 
cutaneous or mucocutaneous vesicular eruption that is generally limited to the 
affected dermatome (113). The commonest prodromes are pain, itching and 
paresthesia (114-116)  
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• Canker sores: Canker sores or apthous ulcers are painful and round white sores 
with a red border that occur inside the mouth. There is a tingling or burning 
sensation prior to the appearance of the sores. They are associated with various 
nutritional and immunological deficiencies. However, they are more common in 
individuals with acute HIV infection (117, 118).  
• Lyme disease: Lyme disease, caused by the tick-borne spirochete Borrelia 
burgdorferi, is associated with a wide variety of neurologic manifestations. 
Neuropathic symptoms such as symmetric, distal and nonpainful paresthesia, and 
asymmetric radicular pain begin 8 months after erythema migrans occurs and are 
present for up to 12 months (119, 120) 
• Human Immunodeficiency Virus type-1 (HIV-1): Peripheral neuropathies 
commonly complicate all stages of the HIV-1 disease. Whereas symptomatic 
neuropathies occur in approximately 10% to 15% of HIV-1-infected patients overall, 
pathologic evidence of peripheral nerve involvement is present in virtually all end-
stage AIDS patients. The dominant clinical features in distal sensory 
polyneuropathy which is the most common among the HIV-1-associated 
neuropathies include distal pain, paresthesia and numbness in a typical length-
dependent fashion with a proximal to distal gradient (121, 122). 
• Leprosy: Leprosy is a slowly progressive, chronic infectious disease caused by the 
bacillus Mycobacterium leprae. The skin and peripheral nerves are the most 
commonly affected organs (123). Predominant presenting symptoms are 
paresthesia, pain and sensory/motor deficit (124). 
• Syphilis: Neurosyphilis may cause paresthesia (125, 126). Paresthesia can be due to 
spinal myelitis caused by neurosyphilis (127).  
• Guillain-Barré syndrome (GBS): GBS is an acute, symmetrical polyneuropathy with 
distinctive features. The early clinical course involves painful paresthesia that is 
usually followed by proximal motor weakness (128). Some infectious pathogens 
may play a role in the pathogenesis of GBS (129). 
• Rabies: Rabies, which is an acute, progressive, fatal zoonotic infectious disease, is 
almost always caused by the bite of rabid animals (130, 131). The rabies virus 
travels to the brain by following the peripheral nerves. Once the rabies virus 
reaches the central nervous system and symptoms begin to show, the infection is 
effectively untreatable and usually fatal within days. Early-stage symptoms of 
rabies are malaise, headache and fever, progressing to acute pain, paresthesia, 
violent movements and hydrophobia (132). 
• Autoimmune diseases 
• Rheumatoid arthritis: Dry mouth, pruritus and paresthesia are frequent complaints 
in patients with rheumatoid arthritis (133). Rheumatoid cervical myelopathy causes 
paresthesia in the arms and neck pain (134).  
• Systemic lupus erythematosus (See Systemic lupus erythematosus in Central nervous 
system etiologies) 
• Sjogren's syndrome: Peripheral neuropathy occurs in Sjogren's syndrome. The 
history often reveals complaints of burning, tingling paresthesias in a symmetrical 
stocking or glove distribution or in the face (Trigeminal Nerve) area (135-137). 
• Pernicious anemia (See Vitamin B12 deficiency in Central nervous system etiologies) 
• Diabetes (See Diabetes in Methabolic disorders)  
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• Arthritis: The involvement of the cervical spine is the most serious skeletal 
manifestation of rheumatoid arthritis. In patients with basilar impression 
and/or rheumatoid cervical myelopathy, paresthesia in the upper limbs was 
significantly more common (134, 138). Paresthesia can occur in psoriatic 
arthritis (139). 
• Fibromyalgia: Fibromyalgia is a frequent disorder of the middle aged, 
particularly in women characterized by chronic, diffuse musculoskeletal pain 
and by a low pain threshold at specific anatomical points (tender points) (140). 
Cacace et al. found that paresthesia had the highest frequency among 
associated clinical distress in fibromyalgia (141). 
• Nutrient deficiency 
• Vitamin B1: Thiamine (vitamin B1) deficiency leads to Beri-Beri which takes two 
forms. Dry beri-beri has symptoms of peripheral neuropathy with ataxia, 
weakness, paresthesia, and patchy sensory loss with areflexia (142). 
• Vitamin B5: It seems that pantothenic acid (vitamin B5) can cause sensory 
polyneuropathy (143). 
• Vitamin B6: The symptoms related to pyridoxine (vitamin B6) deficiency are 
peripheral neuropathies, such as paresthesia and burning dysesthesias (104).  
• Vitamin B12 (See Vitamin B12 deficiency in Central nervous system etiologies) 
• Malignancies: Local paresthesia can be caused by a malignancy which puts 
pressure on adjacent nerves. For example a reported osteosarcoma in the left 
segment of the maxilla led to swelling and paresthesia in the left cheek (144), 
and periorbital paresthesia is usually a sign of malignancy (145). Multiple 
myeloma with extraosseous lesions may result in paresthesia of soft tissue 
(146). On the other hand the association between polyneuropathy and multiple 
myeloma as the result of various clinical variants should be considered (147). 
POEMS syndrome which is identified as Polyneuropathy, Organomegaly, 
Endocrinopathy, Monoclonal Gammopathy and Skin changes, presents with 
abdominal distension, progressive paresthesia and motor weakness of both 
lower extremities (148). 
• Skin disorders 
• Burns: Studies of patients recovering from significant burns show that abnormal 
sensations such as paresthesia are frequently reported as long as several years after 
the injury (149, 150). Furthermore long-term paresthesia is a complication reported 
after electrical burns (151, 152). 
• Frostbite: Frostbite injuries occur mainly in the toes, fingers, ears, nose and cheek. 
Typically an initial vasoconstriction in the skin will protect against drop in core 
temperature. Ice crystal development occurs when tissue temperature drops to -2° 
C, leading to increased osmolality of the extracellular fluid and intracellular 
dehydration. White-cyanotic discoloration, pain and paresthesia followed by 
hypoesthesia are the symptoms of frostbite injury (153). 
• Ito syndrome: Hypomelanosis of Ito is a rare neurocutaneous disorder. It is 
characterized by depigmented skin areas often associated with ocular, 
musculoskeletal and neurological abnormalities (154).  
• Pink disease: Acrodynia (pink disease) occurs in children exposed to mercury for 
prolonged periods (155). Affected patients are initially listless, anorexic, and 
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irritable. Their blood pressure and heart rate increase. Significant pain occurs in the 
hands and feet preventing sleep. Finally the hands and feet will swell and become 
paresthetic, becoming a dusky pink color along with a similar process which occurs 
in the nose (156). 
• Acroparesthesia: Postmenopausal women may experience acroparesthesia. 
Hormone therapy can increase forearm/hand blood flow, and help ameliorate 
these symptoms (157). 
• Migraine: The somatosensory aura of a migraine may consist of digitolingual 
or cheiro-oral paresthesias. The paresthesia may migrate up the arm and then 
extend to involve the face, lips and tongue (158).  
• Psychological disorders: Anxiety, panic attack and psychiatric diseases may 
cause hyperventilation which can lead to paresthesia (6). Paresthesia also can 
be a manifestation of depression (159).  
• Medications: Paresthesia can be a side effect of some medications such as anti-
convulsant drugs, topiramate, amiodarone, digoxin, dimercaprol, 
colistimethate, mefloquine, metronidazole, HIV medications, riluzole, 
tetrodotoxin, thallium, vincristine, diphenoxylate, overdose of lidocain or 
vitamin B6 (1). Sertraline can induce facial paresthesia (160). SSRI withdrawal 
may cause paresthesia. The neurotoxicity of immuno-suppressive agents (e.g. 
calcineurin-inhibitors) may cause mild symptoms, such as tremors and 
paresthesia (161). Motexafin lutetium which is used in the treatment of 
coronary atherosclerosis or vulnerable plaque can cause the paresthesia (23).  
• Toxins 
• Alcohol (See Alcoholism in Metabolic disorders)  
• Tobacco: Smoking is a strong risk factor for arteriosclerosis and Buerger's disease 
which can cause sensitive axonal polyneuropathy (15, 162). 
• Drug abuse: Intravenous administrating of strong pharmaceutical drugs acting on 
the central nervous system, mainly opioids especially in non-medical use (drug 
abuse) can lead to neurological manifestations such as paresthesia (1).  
• Heavy metals  
• Mercury: toxicity from organic mercurials includes neurologic decompensation 
with mental deterioration, ataxia, spasms, paresthesia, deafness, and 
eventually coma (156).  
• Arsenic: Neurological and neurophysiological studies indicate that the 
functions of the central and peripheral nervous system may be impaired under 
conditions of exposure to arsenic (163). 
• Lead: The prominent findings among the lead-exposed workers are fatigue, 
abdominal discomfort, backache, myalgia and paresthesia (164). 
• Nitrous oxide: Exposure to nitrous oxide may damage the nervous system which 
can lead to ascending paresthesia of the limbs, severe ataxia of gait, tactile sensory 
loss on the limbs and trunk, and absent tendon reflexes (165, 166).  
• Carbon monoxide: Paresthesia, emesis, diarrhea, unilateral headache, palpitation or 
death are non-specific but common symptoms of carbon monoxide poisoning (167). 
• Snake bites: Some venom contains toxins which attack the nervous system, causing 
neurotoxicity. The victim may present with strange disturbances to their vision, 
paresthesia, difficulty speaking and respiratory paralysis (168). 
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• Ciguatera: Ciguatera is the most frequently observed form of tropical fish 
poisoning. It blocks the sodium channel leading to slowed nerve conduction and 
causes the peripheral and central nervous system symptoms such as facial 
paresthesia, myalgia, cramps and weakness. Ciguatera poisoning leads to the 
gastrointestinal and cardiovascular disturbances too (169, 170). 
• Radiation exposure: Chronic progressive radiation myelopathy develops with a 
latency of several months to years after spinal cord irradiation. The symptoms 
are paresthesia, paresis or paralysis, leading to severe physical disability (171). 
• Chemotherapy: Intrathecal injections of cytarabine and methotrexate can lead 
to paresthesias and weakness causing patient to be wheelchair bound (172).  
• Hereditary diseases 
• Fabry disease: Fabry syndrome is a genetic disease related to changes on the X 
chromosome. It is caused by deficient activity of alpha-galactosidase A and is 
characterized by intralysosomal storage of glycosphingolipids. The main clinical 
features are paresthesia, hypohidrosis, angiokeratoma, renal insufficiency, and 
cardiovascular or cerebral complications (173, 174).  
• Refsum syndrome: Refsum's disease is an autosomal recessive disorder with 
clinical features that include retinitis pigmentosa, blindness, anosmia, deafness, 
sensory neuropathy, ataxia and accumulation of phytanic acid in plasma- and 
lipid-containing tissues (175). 
• Charcot-Marie-Tooth disease (See Charcot-Marie-Tooth disease in Peripheral nervous 
system etiologies) 
• Porphyria (See Porphyria in Metabolic disorders)  
• Ataxia-teleangiectasia: Ataxia-telangiectasia is a progressive neurodegenerative 
disorder, with onset in early childhood. It is an autosomal recessive disorder that 
includes progressive cerebellar ataxia, dysarthric speech, oculomotor apraxia, 
choreoathetosis and, later, oculocutaneous telangiectasia (176, 177).  
• Immune deficiency: The immune response dysfunction induced by the human 
immunodeficiency virus infection sometimes causes inflammatory lesions of 
the central and peripheral nervous system leading to neurological symptoms 
such as paresthesia (178). 
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